Marco Gobbi
Marco Gobbi
IRCCS Istituto di Ricerche Farmacologiche Mario Negri
Verified email at marionegri.it - Homepage
Title
Cited by
Cited by
Year
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein
C Balducci, M Beeg, M Stravalaci, A Bastone, A Sclip, E Biasini, L Tapella, ...
Proceedings of the National Academy of Sciences 107 (5), 2295-2300, 2010
4612010
Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines.
S Sozzani, W Luini, A Borsatti, N Polentarutti, D Zhou, L Piemonti, ...
The Journal of Immunology 159 (4), 1993-2000, 1997
4231997
Regulation of leukocyte recruitment by the long pentraxin PTX3
L Deban, RC Russo, M Sironi, F Moalli, M Scanziani, V Zambelli, ...
Nature immunology 11 (4), 328-334, 2010
3832010
A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis
G Di Fede, M Catania, M Morbin, G Rossi, S Suardi, G Mazzoleni, ...
Science 323 (5920), 1473-1477, 2009
3652009
Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6
AM Fra, M Locati, K Otero, M Sironi, P Signorelli, ML Massardi, M Gobbi, ...
The Journal of Immunology 170 (5), 2279-2282, 2003
2222003
Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis
M Morigi, M Galbusera, S Gastoldi, M Locatelli, S Buelli, A Pezzotta, ...
The Journal of Immunology 187 (1), 172-180, 2011
2162011
Carrier‐dependent and Ca2+‐dependent 5‐HT and dopamine release induced by (+)‐amphetamine, 3, 4‐methylendioxy‐methamphetamine, p‐chloroamphetamine and (+)‐fenfluramine
D Crespi, T Mennini, M Gobbi
British journal of pharmacology 121 (8), 1735-1743, 1997
2101997
Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1
E Fumagalli, M Funicello, T Rauen, M Gobbi, T Mennini
European journal of pharmacology 578 (2-3), 171-176, 2008
2072008
The antidepressant mechanism of Hypericum perforatum
T Mennini, M Gobbi
Life sciences 75 (9), 1021-1027, 2004
1962004
Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide
S Mourtas, M Canovi, C Zona, D Aurilia, A Niarakis, B La Ferla, ...
Biomaterials 32 (6), 1635-1645, 2011
1942011
An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo
BR Fluharty, E Biasini, M Stravalaci, A Sclip, L Diomede, C Balducci, ...
Journal of Biological Chemistry 288 (11), 7857-7866, 2013
1652013
Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy
F NoŔ, AH Pool, J Nissinen, M Gobbi, R Bland, M Rizzi, C Balducci, ...
Brain 131 (6), 1506-1515, 2008
1622008
Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide
M Gobbi, F Re, M Canovi, M Beeg, M Gregori, S Sesana, S Sonnino, ...
Biomaterials 31 (25), 6519-6529, 2010
1562010
Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study
L Obici, A Cortese, A Lozza, J Lucchetti, M Gobbi, G Palladini, S Perlini, ...
Amyloid 19 (sup1), 34-36, 2012
1532012
Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor
R Bonecchi, M Locati, E Galliera, M Vulcano, M Sironi, AM Fra, M Gobbi, ...
The Journal of Immunology 172 (8), 4972-4976, 2004
1492004
Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial
S Ha´k, G Marcon, A Mallet, M Tettamanti, A Welaratne, G Giaccone, ...
The Lancet Neurology 13 (2), 150-158, 2014
1332014
Development of a proteolytically stable retro-inverso peptide inhibitor of β-amyloid oligomerization as a potential novel treatment for Alzheimer’s disease
M Taylor, S Moore, J Mayes, E Parkin, M Beeg, M Canovi, M Gobbi, ...
Biochemistry 49 (15), 3261-3272, 2010
1292010
PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer’s disease
D Brambilla, R Verpillot, B Le Droumaguet, J Nicolas, M Taverna, J Kˇna, ...
ACS nano 6 (7), 5897-5908, 2012
1272012
Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer’s disease
B Le Droumaguet, J Nicolas, D Brambilla, S Mura, A Maksimenko, ...
ACS nano 6 (7), 5866-5879, 2012
1262012
Recombinant C1 inhibitor in brain ischemic injury
R Gesuete, C Storini, A Fantin, M Stravalaci, ER Zanier, F Orsini, ...
Annals of Neurology: Official Journal of the American Neurologicalá…, 2009
1222009
The system can't perform the operation now. Try again later.
Articles 1–20